TERT and medulloblastoma: According to this view, it is not surprising that TERT promoter mutations have been observed in >80% of primary glioblastomas; in other brain tumors, the frequency of TERT promoters mutations was high in oligodendrogliomas, but mutations were much less frequent in medulloblastomas, astrocytomas, and ependymomas [18].